Stay updated with breaking news from Viz Platform. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
New partnership incorporates latest perfusion technology into the Viz.ai platform Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced a partnership
Viz.ai and Vastrax Join Forces to Accelerate Clinical Trial Enrollment - read this article along with other careers information, tips and advice on BioSpace
Viz.ai announced today that it received FDA 510(k) clearance for its automated RV/LV ratio algorithm as part of the Viz PE solution.
Viz.ai announced today that it received FDA 510(k) clearance for its Viz Subdural (SDH) artificial intelligence (AI) algorithm.
The company’s platform has raised $100 million in its latest round, and shows no signs of stopping.